Clinical Trial Update: Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial [Phase 3]

View source ↗

Summary

A multicenter Phase 3 trial is evaluating toripalimab as adjuvant therapy after esophageal cancer surgery; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Esophageal Cancer | Phase 3 | Status: NOT_YET_RECRUITING